Vaccines: USA, Moderna and Pfizer study at the ‘photo finish’
(ANSA) – ROME, 02 DEC – The Moderna and Pfizer-BioNTech vaccines both have a very high efficacy, but the former offers a slightly higher protection.
(ANSA) – ROME, 02 DEC – The Moderna and Pfizer-BioNTech vaccines both have a very high efficacy, but the former offers a slightly higher protection.
(ANSA) – ROME, 02 DEC – Myocarditis after vaccination against Covid-19 are rare and, in most cases, mild events. The confirmation comes from an Israeli
(ANSA) – BOLZANO, 02 DEC – In the province of Bolzano, “in the week from 24 to 30 November, a worsening performance is recorded for
(ANSA) – PERUGIA, 02 DEC – Umbria again exceeds 4,000 daily doses of third doses of Covid vaccine, 4,344 in the last 24 hours, with
(ANSA) – BOLZANO, 02 DEC – Alto Adige, with a stroke of the kidneys, tries to recover the vaccination rankings. From 10 to 12 December
(ANSA) – BRUSSELS, DECEMBER 01 – Up to 4.2 billion doses of vaccine guaranteed by the EU strategy, 76% of the adult population in the
(ANSA) – MILAN, NOVEMBER 30 – The CEO of Moderna, Stéphane Bancel, expects a “substantial decline” in the effectiveness of the current vaccines against the
(ANSA) – ROME, NOV 29 – Vaccines guarantee a certain efficacy even against the Omicron variant. Indeed, it is “unlikely” that the virus “escapes entirely”.
He was vaccinated with two doses, he promised himself to take the third as soon as his work commitments in the world allowed him to
(ANSA) – BARI, 27 NOV – “The anti Covid vaccination campaign with third dose has started in an extraordinary way,” I want to thank all